Literature DB >> 23873785

Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.

Bernd Hartz1, Ulrike Löbel, Christian Hagel, Gabriele Escherich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873785     DOI: 10.1002/ajh.23550

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication.

Authors:  Maria Chiara Tisi; Giuseppe Ausoni; Maria Gabriella Vita; Tommaso Tartaglione; Mario Balducci; Luca Laurenti; Patrizia Chiusolo; Stefan Hohaus; Simona Sica
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-03-01       Impact factor: 2.576

2.  Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.

Authors:  Annalisa Lonetti; Alessandra Cappellini; Alice Bertaina; Franco Locatelli; Andrea Pession; Francesca Buontempo; Camilla Evangelisti; Cecilia Evangelisti; Ester Orsini; Laura Zambonin; Luca Maria Neri; Alberto Maria Martelli; Francesca Chiarini
Journal:  J Hematol Oncol       Date:  2016-10-24       Impact factor: 17.388

3.  Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant.

Authors:  Ashley McEwan; Omali Pitiyarachchi; Nicholas Viiala
Journal:  Hemasphere       Date:  2020-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.